ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Compare Bosutinib To Imatinib In Subjects With Newly Diagnosed Chronic Phase Philadelphia Chromosome Positive CML

ClinicalTrials.gov ID: NCT00574873

Public ClinicalTrials.gov record NCT00574873. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 23, 2026, 7:08 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A PHASE 3 RANDOMIZED, OPEN-LABEL STUDY OF BOSUTINIB VERSUS IMATINIB IN SUBJECTS WITH NEWLY DIAGNOSED CHRONIC PHASE PHILADELPHIA CHROMOSOME POSITIVE CHRONIC MYELOGENOUS LEUKEMIA

Study identification

NCT ID
NCT00574873
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pfizer
Industry
Enrollment
502 participants

Conditions and interventions

Interventions

  • Bosutinib Drug
  • imatinib Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 4, 2008
Primary completion
Aug 30, 2010
Completion
May 26, 2015
Last update posted
Jan 7, 2019

2008 – 2015

United States locations

U.S. sites
32
U.S. states
13
U.S. cities
25
Facility City State ZIP Site status
Pacific Cancer Medical Center Inc Anaheim California 92801
Tower Cancer Research Foundation (TCRF) Beverly Hills California 90211-1848
Robert A Moss, MD, FACP, Inc Fountain Valley California 92708
UCSD Medical Center-Thornton La Jolla California 92037
UCSD Moores Cancer Center La Jolla California 92093
UCSD Medical Center-Hillcrest San Diego California 92103
Stanford Hospital and Clinics Investigational Drug Services Stanford California 94305
Stanford Hospitals and Clinics Stanford California 94305
Stanford University Medical Center Stanford California 94305
Cancer Care Centers of Florida Hudson Florida 34667
Cancer Care Centers of Florida New Port Richey Florida 34652
Pasco Pinellas Cancer Center New Port Richey Florida 34652
Orlando Health, Inc. Orlando Florida 32806
Pasco Pinellas Cancer Center Tarpon Springs Florida 34689
Northside Hospital, Inc. - GCS/Annex Atlanta Georgia 30341
Indiana Blood and Marrow Transplantation Research Franciscan St. Francis Health Center Inc. Indianapolis Indiana 46237
Indiana Blood and Marrow Transplantation Research Indianapolis Indiana 46237
Siouxland Hematology-Oncology Associates, LLP Sioux City Iowa 51101
Cancer Center of Kansas Salinas Kansas 67401
Cancer Center of Kansas Wichita Kansas 67214
Kentucky Cancer Clinic Hazard Kentucky 41701-9466
Center for Cancer and Blood Disorders Bethesda Maryland 20817
Josephine Ford Cancer - Downriver Brownstown Michigan 48183
Henry Ford Medical Center- Fairlane Dearborn Michigan 48126
Henry Ford Hospital Detroit Michigan 48202-2689
Henry Ford Hospital - West Bloomfield Detroit Michigan 48322
Regional Cancer Care Associates Cherry Hill New Jersey 08003
Study Supplies: Regional Cancer Care Associates Cherry Hill New Jersey 08003
Somerset Hematology Oncology Associates Somerville New Jersey 08876
San Juan Oncology Associates Farmington New Mexico 87401
Associates In Oncology and Hematology Chattanooga Tennessee 37421
The University of Texas M.D. Anderson Cancer Center Houston Texas 77030-4009

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 133 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00574873, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 7, 2019 · Synced Apr 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00574873 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →